Research Study for ARCI-lamellar ichthyosis
Therapeutics Clinical Research (TCR) is a clinical research facility that tests the safety and effectiveness of investigational medications prior to FDA approval. We run a variety of clinical trials on dermatological diseases such as acne, psoriasis, rosacea, actinic keratosis, hair loss, ichthyosis and cosmetic treatments.
We are a hybrid of clinical research and private practice. On site, we have a fully staffed team who ensure all research participants receive proper care throughout the research trial.
We are dedicated to providing a friendly, caring environment in which the needs and concerns of our patients are the priority while meeting the expectations set forth by a given study protocol.
We are driven by our core values: community, ethics, and trust.
Currently, our site is conducting a clinical research study evaluating an investigational topical medication for lamellar ichthyosis. The clinical research conducted at TCR is directed towards finding more effective treatments for people with this ichthyosis.
Qualified participants receive:
- Study-related skin examinations by a board-certified study doctor
- All study visits and study medications at no cost
- Compensation up to $627 for time and travel
or visit: https://www.therapeuticsresearch.com/